Fosmetpantotenate (RE-024), a phosphopantothenate replacement therapy for pantothenate kinase-associated neurodegeneration: Mechanism of action and efficacy in nonclinical models
Table 4
Blood pharmacokinetics of fosmetpantotenate, PPA, and PA in male mice, rats, and monkeys following a single PO dose of fosmetpantotenatea.